Single Ascending Dose Study of CM326 in Healthy Volunteers

NCT04842201 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: CM326
DRUG: Placebo

Sponsor

Keymed Biosciences Co.Ltd